Virginia Retirement Systems Et Al X Biotech Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$15.92 - $20.3 $165,568 - $211,120	-10,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.65 - $19.92 $17,215 - $21,912	-1,100 Reduced 9.57%	10,400 $163,000
Q3 2020 Nov 12, 2020	SELL	$13.97 - $21.16 $54,483 - $82,524	-3,900 Reduced 25.32%	11,500 $220,000
Q2 2020 Aug 12, 2020	BUY	$10.39 - $16.07 $160,006 - $247,478	15,400 New	15,400 $211,000

4.7M

200

12.8K

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $94.4M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.